Krystal Biotech, Inc. (KRYS)

NASDAQ: KRYS · Real-Time Price · USD

341.12

-25.73 (-7.01%)

At close: Jul 31, 2026, 4:00 PM EDT

340.00

-1.12 (-0.33%)

After-hours: Jul 31, 2026, 7:40 PM EDT

Krystal Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	501.31	496.3	344.87	358.33	161.9	341.25
Short-Term Investments	322.09	331.49	252.65	173.85	217.27	96.85
Cash & Short-Term Investments	823.41	827.79	597.52	532.18	379.17	438.1
Cash Growth	33.49%	38.54%	12.28%	40.35%	-13.45%	61.50%
Accounts Receivable	127.02	127.43	104.75	42.04	-	-
Inventory	42.65	40.48	26.51	6.99	-	-
Other Current Assets	26.67	28.91	13.27	6.71	4.61	4.17
Total Current Assets	1,020	1,025	742.05	587.91	383.78	442.27
Net Property, Plant & Equipment	160.62	158.02	161.45	168.23	169.73	119.58
Long-Term Investments	193.49	128.07	152.11	61.95	4.62	64.37
Other Long-Term Assets	23.12	23.11	0.23	0.26	0.32	0.07
Total Assets	1,397	1,334	1,056	818.36	558.45	626.3

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	4.09	3.24	4.99	4.13	3.98	8.4
Accrued Expenses	101.91	97.93	95.79	27.49	23.31	16.3
Current Portion of Leases	1.8	1.77	1.22	1.47	1.56	1.04
Total Current Liabilities	107.8	102.94	102	33.09	28.85	25.74
Long-Term Leases	7.31	7.57	6.04	6.62	7.37	6.98
Other Long-Term Liabilities	5.12	3.72	1.42	-	-	-
Total Long-Term Liabilities	12.44	11.29	7.46	6.62	7.37	6.98
Total Liabilities	120.24	114.23	109.46	39.71	36.22	32.72

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-in Capital	1,198	1,194	1,127	1,048	803.72	734.52
Accumulated Other Comprehensive Income	-1.62	1.14	-0.19	0.64	-0.73	-0.16
Retained Earnings	80.1	24.16	-180.67	-269.83	-280.76	-140.78
Shareholders' Equity	1,277	1,220	946.38	778.64	522.23	593.58
Total Liabilities & Equity	1,397	1,334	1,056	818.36	558.45	626.3

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	9.11	9.34	7.26	8.09	8.93	8.02
Net Cash (Debt)	814.29	818.45	590.26	524.08	370.24	430.07
Net Cash Growth	34.11%	38.66%	12.63%	41.55%	-13.91%	65.59%
Net Cash Per Share	27.07	27.33	19.85	18.89	14.52	19.38
Book Value	1,277	1,220	946.38	778.64	522.23	593.58
Book Value Per Share	42.44	40.72	31.82	28.06	20.49	26.74
Tangible Book Value	1,277	1,220	946.38	778.64	522.23	593.58
Tangible Book Value Per Share	42.44	40.72	31.82	28.06	20.49	26.74

SEC Filings: 10-K · 10-Q